Welcome : Guest

Declining Cost and Expanding Applications to Drive Market Growth for Next Generation Sequencers

Published: March 2017


  • Code: MCP-6811
  • Pages: 295
  • Tables: 47
  • Companies: 93


The global market for Next Generation Sequencers is projected to exceed US$4.2 billion by 2022, driven by large-scale DNA sequencing needs in biomedical research and genetic mapping projects; and development of ultra-high throughput sequencers with improved capabilities. The growth in the market also stands to benefit from expanding applications in areas such as cancer research, biomarker discovery, agricultural and animal sciences and drug discovery. The United States represents the largest market worldwide supported by advanced healthcare technology framework; and increasing R&D investments in proteomic and genomic sequence determination for biomarkers research. Asia-Pacific is poised to grow at the fastest CAGR of 15.1% over the analysis period driven by strong government policy led support of biological research and genotyping projects in China, India and Thailand in an attempt to improve public health and reduce healthcare technology dependence on advanced economies. China is already on-course towards emerging into the world’s new DNA superpower supported by the ambitious precision-medicine initiative. 

    Summary of Findings

  • Growing Number of Projects in DNA Sequencing, Targeted Gene Expression, Human Leukocyte Antigen (HLA) Typing, Metagenomics, Small Genome & Microbial Sequencing to Spur Adoption of Next Generation Sequencers
  • Focus on Internalizing Advances in Biomedicine, Drug Discovery, Biomedical, & Bioinformatics Technologies to Drive Demand for Next Generation Sequencers in Developing Countries
  • Declining Cost of Sequencing Devices and Equipment to Fuel Market Growth
  • Personalized Medicine Drives the Prominence of Next Generation Sequencers in Developing Customized Treatment Plans
  • Growing World Focus on Developing Scientific Infrastructures and the Establishment of Genome Sequencing Centers to Benefit Market Growth

    Timeline for Analysis

  • Market Estimates and Forecasts for 2015-2022
  • Historic Review 2009-2014

    Geographic Markets Analyzed

  • US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), Latin America, and Rest of World

    Market Segmentation & Classification

  • End-Use Segments:
    • Pharmaceutical/Biotech, Industrial, and Government/Academia


  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Genomatix GmbH
  • Illumina, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.


  • Review of Industry/Market Structure
  • Analysis of Trends & Drivers
  • Insights on Macro Market Scenarios
  • Market SWOT Analysis
  • Latent Demand Forecasts & Projections
  • Comprehensive Geographic Market Analysis
  • Presentation Ready Facts & Statistical Data Findings
  • Coverage of Major/Niche Players, Market Shares & Competition
  • Coverage of major Company/Technology/Product/Financial Stories
  • Extensive Product/Service/End-Use/Technology Coverage Where Applicable

Interested in our research, you can contact our 24/7 Research Support e-Desk at rsd@strategyr.com